Clinical Trial Update: Abatacept in Patients With Birdshot HLA A29 Uveitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating abatacept in patients with Birdshot uveitis (HLA-A29 positive). Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birdshot Chorioretinopathy
• Eye Diseases
• Uveitis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Eye Diseases, Uveitis | Phase 2 | Status: COMPLETED